XML 39 R6.htm IDEA: XBRL DOCUMENT v3.24.2
Consolidated Statements of Changes in Shareholders’ Equity - USD ($)
Ordinary shares
Subscription receivables
Additional paid-in capital
Retained earnings (Accumulated deficit)
Accumulated other comprehensive income (loss)
Total
Balance at Mar. 31, 2021 $ 172 $ (172) $ 638,579 $ 3,416 $ 641,995
Balance (in Shares) at Mar. 31, 2021 1,721,250          
Issuance of ordinary shares $ 976 (976)
Issuance of ordinary shares (in Shares) 9,753,750          
Net loss (510,905) (510,905)
Foreign currency translation adjustments (2,388) (2,388)
Balance at Mar. 31, 2022 $ 1,148 (1,148) 127,674 1,028 128,702
Balance (in Shares) at Mar. 31, 2022 11,475,000          
Net loss (207,169) (207,169)
Forgiveness of debt by major shareholders 2,025,475 2,025,475
Net between subscription receivables and additional paid-in capital 1,148 (1,148)
Foreign currency translation adjustments (2) (2)
Balance at Mar. 31, 2023 $ 1,148 2,024,327 (79,495) 1,026 $ 1,947,006
Balance (in Shares) at Mar. 31, 2023 11,475,000         11,475,000 [1]
Issuance of ordinary shares $ 127 794,771 $ 794,898
Issuance of ordinary shares (in Shares) 1,275,000          
Issuance of ordinary shares pursuant to IPO, net of offering cost $ 288 9,343,125 9,343,413
Issuance of ordinary shares pursuant to IPO, net of offering cost (in Shares) 2,875,000          
Share based awards to directors and employees of the Group 1,871,499 1,871,499
Net loss (4,589,478) (4,589,478)
Foreign currency translation adjustments (81,850) (81,850)
Balance at Mar. 31, 2024 $ 1,563 $ 14,033,722 $ (4,668,973) $ (80,824) $ 9,285,488
Balance (in Shares) at Mar. 31, 2024 15,625,000         15,625,000 [1]
[1] Shares and per share data are presented on a retroactive basis to reflect the ordinary shares issuance and share split.